Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
7
×
life sciences
national blog main
boston top stories
national top stories
new york blog main
new york top stories
san francisco blog main
biotech
san francisco top stories
cancer
indiana blog main
indiana top stories
national
sanofi
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston
cancer immunotherapy
celgene
clinical trials
deals
fda
genentech
investing
What
latest
7
×
companies
drug
medicines
new
bets
bio
cancer
medicine
momentum
pharmaceutical
sanofi
therapeutics
address
alzheimer’s
ambitious
american
announced
annual
approval
approves
ash
backs
biotechs
blood
blueprint
borne
cancers
carries
certain
chunk
click
club
comes
conference
continued
country
crop
cut
date
Language
unset
Current search:
latest
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Ireland to Sequence 400K Genomes With New Precision Medicine Effort
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines